Klotho in the cerebrospinal fluid of adults with and without Alzheimer's disease

RD Semba, AR Moghekar, J Hu, K Sun, R Turner… - Neuroscience …, 2014 - Elsevier
The aging-suppressor gene klotho encodes a single-pass transmembrane protein that is
predominantly secreted by the choroid plexus of the brain and in the kidney. Klotho-deficient …

Personality associations with amyloid and tau: Results from the Baltimore Longitudinal Study of Aging and meta-analysis

…, M Luchetti, Y Stephan, AR Moghekar… - Biological …, 2022 - Elsevier
Background Higher neuroticism and lower conscientiousness are risk factors for Alzheimer’s
disease and related dementias, but the underlying neuropathological correlates remain …

[HTML][HTML] The association between personality and plasma biomarkers of astrogliosis and neuronal injury

…, Y An, M Luchetti, Y Stephan, AR Moghekar… - Neurobiology of …, 2023 - Elsevier
Personality traits have been associated with the risk of dementia and Alzheimer’s disease
neuropathology, including amyloid and tau. This study examines whether personality traits are …

Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease

…, M Thambisetty, R O'Brien, AR Moghekar… - Alzheimer's & …, 2019 - Elsevier
Introduction Primary age-related tauopathy (PART) is a recently described entity that can
cause cognitive impairment in the absence of Alzheimer's disease (AD). Here, we compared …

[HTML][HTML] Plasma markers of inflammation linked to clinical progression and decline during preclinical AD

AL Gross, KA Walker, AR Moghekar… - Frontiers in aging …, 2019 - frontiersin.org
Objective To examine the prospective association between blood biomarkers of immune
functioning (ie, innate immune activation, adaptive immunity, and inflammation) and …

Hypothetical preclinical Alzheimer disease groups and longitudinal cognitive change

…, C Pettigrew, Q Cai, MC Wang, AR Moghekar… - JAMA …, 2016 - jamanetwork.com
Importance Clinical trials testing treatments for Alzheimer disease (AD) are increasingly
focused on cognitively normal individuals in the preclinical phase of the disease. To optimize …

Olfaction, cognitive impairment, and PET biomarkers in community-dwelling older adults

Q Tian, M Bilgel, AR Moghekar… - Journal of …, 2022 - content.iospress.com
Background: Olfactory deficits are early features of preclinical Alzheimer’s disease (AD).
Whether olfaction is associated with PET biomarkers among community-dwelling older adults is …

Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid

M Bilgel, Y An, KA Walker, AR Moghekar… - Alzheimer's & …, 2023 - Wiley Online Library
INTRODUCTION Understanding longitudinal plasma biomarker trajectories relative to brain
amyloid changes can help devise Alzheimer's progression assessment strategies. …

Brachial plexopathies: etiology, frequency, and electrodiagnostic localization

AR Moghekar, AR Moghekar, N Karli… - Journal of clinical …, 2007 - journals.lww.com
Objectives: Brachial plexopathy is clinically, and electrodiagnostically, a well-recognized
entity. However, the involvement pattern of different parts of the plexus with different etiologies …

MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging

…, Y An, A Lewis, AR Moghekar… - Annals of clinical …, 2023 - Wiley Online Library
Objective White matter damage is a feature of Alzheimer's disease, yet little is known about
how facets of the Alzheimer's disease process relate to key features of white matter structure. …